Ingen internetforbindelse — viser den gemte version af siden.

藥明生物

WuXi Biologics (Cayman) IncUSUSD
← Til screeneren

WuXi Biologics (Cayman) Inc (US:WXIBF) — Biotechnology. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
wuxibiologics.com
Sektor
Healthcare · Biotechnology
Hovedkontor
Wuxi, China
Administrerende direktør
Dr. Zhisheng Chen Ph.D.
Ansatte
14 705
Udestående aktier
4.12 mia. pr. 2026-10-07
DatoAktierÆndring
07.10.20264.12 mia.—ingen væsentlige ændringer
06.10.20264.12 mia.—ingen væsentlige ændringer
05.10.20264.12 mia.
Antal aktier ifølge børsdata; historikken opbygges over tid. Et aktiesplit registreres ved et spring i antallet med et helt multiplum.
Free float
3.71 mia.
Markedsværdi
233.4 mia. HKD
Insidere
10.12%
Institutionelle investorer
36.36%
Juridisk form
OSBR
ISIN
KYG970081173
LEI
5493001TD2TH6VDTJU11
Beskrivelse

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (“TAA”) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksWXIBF OTCUSD6.77 +0.00%almindelige aktier
HK Hong Kong Stock Exchange2269 primærHKD55.45 -2.20%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Ingen udbyttebetalinger fundet (tjekket 08.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.

Nyheder denne uge

Pressemeddelelser fra virksomhedens investorhjemmeside, opdateret dagligt. Links fører til virksomhedens hjemmeside. Overskrifterne er på originalsproget, som på virksomhedens hjemmeside.

annonce

Største ejere

EjerAndelAktierRapportdato
VANGUARD STAR FUNDS-Vang…1.34%55.13 mio.2026-07-31
VANGUARD Intl Eqy. INDEX…1.27%52.41 mio.2026-07-31
Chen (Zhisheng) (Chief E…≈1.19%49.19 mio.2026-09-11
iShares, Inc.-iShares Co…0.97%40.12 mio.2026-08-31
VANGUARD WORLD FUND-Vang…0.92%37.93 mio.2026-05-31
American Century ETF Tru…0.27%11.01 mio.2026-08-31
J.P. Morgan Exch-Trd Fd.…0.26%10.87 mio.2026-07-31
VANGUARD Intl Eqy. INDEX…0.22%8.96 mio.2026-07-31
iShares, Inc.-iShares MS…0.22%8.91 mio.2026-08-31
Baird Funds Inc-Baird Ch…0.21%8.77 mio.2026-07-31
iShares Trust-iShares MS…0.21%8.76 mio.2026-08-31
Zhou (Weichang) (Chief T…≈0.14%5.6 mio.2025-06-02
Gu (Xuejun Sherry) (Chie…≈0.03%1.37 mio.2026-08-24
Boston Common Asset Mana…0.02%869 0002024-03-31
Li (Ge) (Chairman of the…——2026-01-20